about
The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responsesConformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin AMolecular mechanism of monoamine oxidase A gene regulation under inflammation and ischemia-like conditions: key roles of the transcription factors GATA2, Sp1 and TBPResistance to cadmium and zinc in Acidiphilium symbioticum KM2 is plasmid mediated.The trans-Golgi proteins SCLIP and SCG10 interact with chromogranin A to regulate neuroendocrine secretion.Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension.Hypertension from targeted ablation of chromogranin A can be rescued by the human orthologBoth rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.Neuroendocrine cell type-specific and inducible expression of chromogranin/secretogranin genes: crucial promoter motifs.Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB).Genotyping and meta-analysis of KIF6 Trp719Arg polymorphism in South Indian Coronary Artery Disease patients: A case-control study.Integrated computational and experimental analysis of the neuroendocrine transcriptome in genetic hypertension identifies novel control points for the cardiometabolic syndrome.Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: allele-specific effects on metabolic traits.Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.Organic anion transporter 3 contributes to the regulation of blood pressure.Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation.Chromogranin A: a novel susceptibility gene for essential hypertension.Functional promoter polymorphisms direct the expression of cystathionine gamma-lyase gene in mouse models of essential hypertension.Transcriptional regulation of the novel monoamine oxidase renalase: Crucial roles of transcription factors Sp1, STAT3, and ZBP89.Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1.A dynamic pool of calcium in catecholamine storage vesicles. Exploration in living cells by a novel vesicle-targeted chromogranin A-aequorin chimeric photoprotein.Secretin activation of chromogranin A gene transcription. Identification of the signaling pathways in cis and in trans.Post-Transcriptional Regulation of Renalase Gene by miR-29 and miR-146 MicroRNAs: Implications for Cardiometabolic Disorders.Metal resistance in Acidocella strains and plasmid-mediated transfer of this characteristic to Acidiphilium multivorum and Escherichia coliThe angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse.Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A.Intracellular protein trafficking into catecholamine storage vesicles: novel chimeric photoproteins visualized by deconvolution fluorescence microscopy.Generation of novel plasmids in Escherichia coli S17-1(pSUP106).Integration of metal-resistant determinants from the plasmid of an Acidocella strain into the chromosome of Escherichia coli DH5alpha.Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin.Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.
P50
Q24301790-6612D128-7E6B-472A-9830-BD7F6341DBA3Q27643080-900F13D3-30FB-4A9A-A8E8-3A8A19354509Q28259446-76D503E5-D25C-4870-9202-BDBE180FF6BBQ30843037-32B81667-A461-48C8-BCFD-3BF70D0B4C49Q33343236-56255A1D-1F7C-4298-B0C7-41C040AB6A1BQ33675339-06C6F76F-8E37-413A-B02E-D4575197C200Q33815657-FBD4BE11-DB33-4430-B196-62126B872104Q33865893-F8BCE0F3-D26C-4F13-9153-64FA978B11CEQ33909582-BB20EECB-3A90-4452-8C1E-88D427324EDCQ35001388-B569848F-AF6A-4CC1-B433-8B53F283BEC9Q35860763-D5172529-02BC-428E-9272-5A835F61A224Q35884049-EAB6AAB7-FA55-469D-9C2D-6FADBFA26A6DQ36305467-ED042AE1-2E53-4C8B-AE76-99879B476E0CQ36481887-75201EFD-FE34-489F-9FED-B37233D0446BQ36616568-473F40C5-D8A7-4AE7-93BB-D97A6DD0897BQ36842435-98F10D6C-4BAA-4669-ADA5-010D7C09C6B8Q36957127-2C6E5F51-9257-40BE-8039-096304F0E1C5Q37111953-2A099B25-346A-40D2-9436-F5842977C849Q37187056-B8258988-9EAA-4142-9E1D-60AA3D712B09Q37583609-E9268B5F-9F79-4B74-8068-B80B1AAF7EF8Q37639931-11972C28-6566-4BDD-80EE-ABAA2680657EQ38290123-179BE9C5-5D9B-4A32-8ED2-3B8938673F44Q38303648-31338757-5C5F-4E01-B8DB-2F73E5BBBAADQ38309411-F6D7BF1D-F6BD-4A5B-9B14-F9F59C777BADQ38336844-40852E51-86C7-4F5E-AC1D-4CED1F53AA29Q38356584-18E8F950-97AE-444B-91B8-265A679D8A55Q38854200-A0CE09F8-6676-4E8C-8976-23FA553C33F2Q39803495-571A45CC-B57C-48EA-B5B6-866EB4670C47Q40655015-57C8D3FA-3CF3-4E49-A0A0-7E5BD70A28C8Q40690975-EEA3EB28-7669-4E77-8CED-808B9DABCCC3Q42511816-52874818-5E77-4567-ABB2-2009640FD16CQ43449628-90D20D98-F8A4-4184-8268-565D6657A89BQ43502817-2F685BFE-799F-4AB7-8ACB-ED0A44B68B27Q44000789-92E82C12-4E55-47AA-A6FE-1D84C439C949Q44216719-CE075D28-D432-4AE9-B10B-E0E084583EE8Q44220619-E09EB90C-168A-48D3-A4DB-CFD8BC02042AQ44431192-820ABF0C-12C9-43D5-8239-A90C1B94C2EFQ45258529-4965DE44-729E-4DAB-BF5E-27991DD55053Q45989523-7BA3F973-6C45-411A-AA78-60A7691243C8Q46012825-D238F449-A936-4ADB-9088-7B7E6C51E540
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nitish R. Mahapatra
@ast
Nitish R. Mahapatra
@en
Nitish R. Mahapatra
@es
Nitish R. Mahapatra
@nl
Nitish R. Mahapatra
@sl
type
label
Nitish R. Mahapatra
@ast
Nitish R. Mahapatra
@en
Nitish R. Mahapatra
@es
Nitish R. Mahapatra
@nl
Nitish R. Mahapatra
@sl
prefLabel
Nitish R. Mahapatra
@ast
Nitish R. Mahapatra
@en
Nitish R. Mahapatra
@es
Nitish R. Mahapatra
@nl
Nitish R. Mahapatra
@sl
P1053
D-4123-2014
P106
P1153
7004619879
P21
P31
P3829
P496
0000-0002-0695-3510